Contrary to the findings that dexmedetomidine attenuated the early postoperative increase in IL-6 after radical gastric or colon cancer surgery (5, 14), there was no difference in the changes of IL-6 between our study groups. The gene discussed is IL6; the disease is malignant colon neoplasm.